4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

424B3 - SRx Health Solutions, Inc. (0001471727) (Filer)

8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

EFFECT - SRx Health Solutions, Inc. (0001471727) (Filer)

424B3 - SRx Health Solutions, Inc. (0001471727) (Filer)

S-1/A - SRx Health Solutions, Inc. (0001471727) (Filer)

10-K - SRx Health Solutions, Inc. (0001471727) (Filer)

144 - SRx Health Solutions, Inc. (0001471727) (Subject)

8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

D - SRx Health Solutions, Inc. (0001471727) (Filer)

8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

NORTH PALM BEACH, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), which recently announced a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), today announced that EMJX is enhancing its Gen2 digital-asset treasury operating system through the integration of OpenAI's latest-generation large language models (LLMs) to support internal research workflows and risk-management decision support. EMJX is a digital-asset treasury operating system that applies quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. The platform is led by Eric M. Jackson and is built to manag

DENVER, Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions (NYSE:SRXH): A Strategic Pivot Toward Gen2 Digital Treasuries SRx Health Solutions (NYSE:SRXH) headlines the morning with a definitive agreement to acquire EMJ Crypto Technologies (EMJX), marking a transformative shift from traditional healthcare operations toward a next-generation digital-asset treasury platform. The transaction positions SRXH at the intersection of public-market governance and quantitative, AI-enabled treasury management, with closing expected in the first quarter of 2026 pending shareholder approval. Until then, shares will continue trading under the SRXH ticker, with the combined company planning to oper

NORTH PALM BEACH, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced that it has entered into a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), a digital-asset treasury platform designed as a treasury operating system, applying quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Upon completion of the transaction, Eric M. Jackson, Ph.D., Founder and Chief Executive Officer of EMJX, is expected to serve as Chief Executive Officer and Chairman of the combined company. A Gen2 Approach to Digital Asset Treasuries:EMJX is designed as a next-generation

TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the Company has been notified by the NYSE American of unusual trading activity of its Common Shares on November 6, 2025. The Company is not aware of any material developments in its business or affairs beyond those that have been publicly disclosed. Investors should rely solely on the Company's filings with the SEC and its press releases. The Company is issuing this press release pursuant to Section 401(d) of the NYSE American Company Guide. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litiga

TAMPA, Fla., Oct. 17, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced it received a notice from the staff of NYSE American LLC (the "Exchange") that the Company was not in compliance with the Exchange's continued listing standards under Section 1003(a)(ii) of the NYSE American Company Guide. Section 1003(a)(ii) requires a listed company to have stockholders' equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. SRx Health is subject to the procedures and requirements of Section 1009 of the Company Guide. The Company has until Novembe

TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

TAMPA, Fla., Aug. 29, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced the cancellation of an additional 350,000 shares, increasing the total number of shares canceled to over 19 million shares of its capital stock. The cancellation was executed under a Settlement, Share Forfeiture and Mutual Release Agreement with certain founders and former officers of its Canadian subsidiary, SRx Health Solutions (Canada), Inc., and related parties. Under to the Settlement Agreement, certain founders and former officers of SRx Canada have forfeited approximately 19 million exchangeable shares, which were ori

TAMPA, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that on August 20, 2025, it received an official notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (the "Exchange") as set forth in Section 1007 of the NYSE American Company Guide. The notice was issued because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the "Delinquent Report") with the Securities and Exchange Commission (the "SEC") by the required due date of August 19, 2025. During

TAMPA, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) ("SRx Health" or the "Company"), a leading global health and wellness company, today announced that is has signed a non-binding Letter of Intent to purchase 100% of the assets of Royal Uranium Inc., a leading uranium royalty business with a portfolio spanning Canada, Colombia, Argentina and Namibia. The acquisition is subject to customary closing conditions, including the negotiation and execution of definitive transaction agreements. Following the closing of this potential transaction, the Company intends to adopt a new corporate name and new ticker symbol, reflecting its expanded mission to combin

TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

TAMPA, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced the appointment of current President, Kent Cunningham, as CEO, and current CEO, Adesh Vora, as Vice Chairman effective immediately. About SRx Health Solutions, Inc. SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry kn

EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE:SRXH) (the "Company" or "SRx", previously known as "Better Choice"), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy in our domestic business and have implemented marketing investment shifts to grow brand awareness and discoverability," says Kent Cunningham, CEO of SRx. "We are focused on optimizing our port

TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced it will host a conference call and webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss its financial results for the first quarter 2025 and provide a business update. Conference Call and Webcast Information:Event: First Quarter 2025 Financial Results Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern TimeLive Call: 1-844-825-9789 or 1-412-317-5180Webcast:  https://srxhealth.com/events-and-presentations/ For interested individuals unable to join the conference call, the webcast replay of the call will